Literature DB >> 1563065

Anaesthesia for Charcot-Marie-Tooth disease: a review of 86 cases.

J F Antognini1.   

Abstract

Operative charts were reviewed in 86 patients with Charcot-Marie-Tooth disease, a condition characterized by chronic muscular denervation. A total of 161 surgical procedures was performed. Major complications were few, and only one operative death occurred, unrelated to anaesthesia. Succinylcholine and malignant hyperthermia triggering agents were used in 41 (48%) and 77 (90%) patients, respectively, without untoward effects. Contrary to previous reports, this survey supports the safe use of succinylcholine and MH triggering agents in this disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1563065     DOI: 10.1007/BF03009054

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  13 in total

1.  Pathophysiology of hyperkalemia induced by succinylcholine.

Authors:  G A Gronert; R A Theye
Journal:  Anesthesiology       Date:  1975-07       Impact factor: 7.892

2.  Phrenic involvement in Charcot-Marie-Tooth disease. A pathologic documentation.

Authors:  D Gilchrist; C K Chan; J H Deck
Journal:  Chest       Date:  1989-11       Impact factor: 9.410

3.  Respiratory muscle dysfunction in hereditary motor sensory neuropathy, type I.

Authors:  P Q Eichacker; A Spiro; M Sherman; E Lazar; J Reichel; F Dodick
Journal:  Arch Intern Med       Date:  1988-08

4.  Succinylcholine-induced hyperkalemia in neuromuscular disease.

Authors:  L H Cooperman
Journal:  JAMA       Date:  1970-09-14       Impact factor: 56.272

5.  Anaesthesia for abdominal hysterectomy in Charcot-Marie-Tooth disease. A case report.

Authors:  J A Roelofse; E A Shipton
Journal:  S Afr Med J       Date:  1985-04-13

6.  Anesthetic management for cesarean section of a patient with Charcot-Marie-Tooth disease.

Authors:  J E Brian; G D Boyles; J G Quirk; R B Clark
Journal:  Anesthesiology       Date:  1987-03       Impact factor: 7.892

7.  [Anesthetic and postoperative management of Charcot-Marie-Tooth disease associated with vocal cord paralysis].

Authors:  T Watanabe; M Yamashita; Y Kondo; S Sato; T Mizutani; T Watanabe; H Naito
Journal:  Masui       Date:  1982-05

8.  Respiratory muscle weakness in Charcot-Marie-Tooth disease. A field study.

Authors:  B N Nathanson; D G Yu; C K Chan
Journal:  Arch Intern Med       Date:  1989-06

9.  Diaphragm weakness in Charcot-Marie-Tooth disease.

Authors:  C M Laroche; N Carroll; J Moxham; N N Stanley; R J Evans; M Green
Journal:  Thorax       Date:  1988-06       Impact factor: 9.139

10.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

View more
  6 in total

Review 1.  The preoperative neurological evaluation.

Authors:  John Probasco; Bogachan Sahin; Tung Tran; Tae Hwan Chung; Liana Shapiro Rosenthal; Zoltan Mari; Michael Levy
Journal:  Neurohospitalist       Date:  2013-10

2.  Anesthetic Management of a Patient With Charcot-Marie-Tooth Disease.

Authors:  Naohiro Ohshita; Saeko Oka; Kaname Tsuji; Hiroaki Yoshida; Shosuke Morita; Yoshihiro Momota; Yasuo M Tsutsumi
Journal:  Anesth Prog       Date:  2016

3.  Anesthetic management in Charcot-Marie-Tooth disease type 2 due to a mutation in the mitofusin-2 gene.

Authors:  Paolo Vinci; Giovanni Lapi
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-04

4.  Anesthesia in a patient with Charcot-Marie-Tooth disease with pneumothorax: a case report.

Authors:  Jae Won Kim; Goo Kim; Tae Woo Kim; Woong Han; Jin Hyun Maeng; Chang Young Jeong; Jin Ho Choi; Dong Ho Park
Journal:  J Int Med Res       Date:  2019-10-20       Impact factor: 1.671

5.  Anaesthetic implications in patient with Charcot-Marie-Tooth disease.

Authors:  Hemlata Kapoor; Milin Shah; Suhani Desai
Journal:  Indian J Anaesth       Date:  2021-07-23

6.  Catheter-based distal sciatic nerve block in patients with Charcot-Marie-Tooth disease.

Authors:  Hubert J Schmitt; Sandra Huberth; Horst Huber; Tino Münster
Journal:  BMC Anesthesiol       Date:  2014-02-14       Impact factor: 2.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.